160 related articles for article (PubMed ID: 26669003)
21. Combinatorial synthesis and characterization of new asymmetric porphyrins as potential photosensitizers in photodynamic therapy.
Fagadar-Cosma E; Cseh L; Badea V; Fagadar-Cosma G; Vlascici D
Comb Chem High Throughput Screen; 2007 Jul; 10(6):466-72. PubMed ID: 17896942
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of vascular effect of Photodynamic Therapy in chorioallantoic membrane using different photosensitizers.
Buzzá HH; Silva LV; Moriyama LT; Bagnato VS; Kurachi C
J Photochem Photobiol B; 2014 Sep; 138():1-7. PubMed ID: 24892978
[TBL] [Abstract][Full Text] [Related]
23. Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes.
Laroui N; Coste M; Lichon L; Bessin Y; Gary-Bobo M; Pratviel G; Bonduelle C; Bettache N; Ulrich S
Int J Pharm; 2019 Oct; 569():118585. PubMed ID: 31376467
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of photodynamic therapy on WM35 melanoma with synthetic porphyrins: Role of chemical structure, intracellular targeting and antioxidant defense.
Baldea I; Olteanu DE; Bolfa P; Ion RM; Decea N; Cenariu M; Banciu M; Sesarman AV; Filip AG
J Photochem Photobiol B; 2015 Oct; 151():142-52. PubMed ID: 26257158
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers.
Smijs TG; van der Haas RN; Lugtenburg J; Liu Y; de Jong RL; Schuitmaker HJ
Photochem Photobiol; 2004; 80(2):197-202. PubMed ID: 15244503
[TBL] [Abstract][Full Text] [Related]
26. Sewage bacteriophage photoinactivation by cationic porphyrins: a study of charge effect.
Costa L; Alves E; Carvalho CM; Tomé JP; Faustino MA; Neves MG; Tomé AC; Cavaleiro JA; Cunha A; Almeida A
Photochem Photobiol Sci; 2008 Apr; 7(4):415-22. PubMed ID: 18385883
[TBL] [Abstract][Full Text] [Related]
27. Photosensitizers Based on G-Quadruplex Ligand for Cancer Photodynamic Therapy.
Kawauchi K; Urano R; Kinoshita N; Kuwamoto S; Torii T; Hashimoto Y; Taniguchi S; Tsuruta M; Miyoshi D
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198362
[TBL] [Abstract][Full Text] [Related]
28. Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies.
Pucelik B; Paczyński R; Dubin G; Pereira MM; Arnaut LG; Dąbrowski JM
PLoS One; 2017; 12(10):e0185984. PubMed ID: 29016698
[TBL] [Abstract][Full Text] [Related]
29. Boosting Type-I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy.
Sun H; Guo R; Guo Y; Song J; Li Z; Song F
Mol Pharm; 2023 Jan; 20(1):606-615. PubMed ID: 36398863
[TBL] [Abstract][Full Text] [Related]
30. Protein-Porphyrin Complex Photosensitizers for Anticancer and Antimicrobial Photodynamic Therapies.
Yamada T; Komatsu T
ChemMedChem; 2023 Dec; 18(23):e202300373. PubMed ID: 37821798
[TBL] [Abstract][Full Text] [Related]
31. Core-shell poly-methyl methacrylate nanoparticles covalently functionalized with a non-symmetric porphyrin for anticancer photodynamic therapy.
Ballestri M; Caruso E; Guerrini A; Ferroni C; Banfi S; Gariboldi M; Monti E; Sotgiu G; Varchi G
J Photochem Photobiol B; 2018 Sep; 186():169-177. PubMed ID: 30064063
[TBL] [Abstract][Full Text] [Related]
32. Trisulfonated porphyrazines: new photosensitizers for the treatment of retinal and subretinal edema.
van Lier JE; Tian H; Ali H; Cauchon N; Hasséssian HM
J Med Chem; 2009 Jul; 52(14):4107-10. PubMed ID: 19514748
[TBL] [Abstract][Full Text] [Related]
33. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
[TBL] [Abstract][Full Text] [Related]
34. Cancer, Photodynamic Therapy and Porphyrin-Type Derivatives.
Gomes ATPC; Neves MGPMS; Cavaleiro JAS
An Acad Bras Cienc; 2018; 90(1 Suppl 2):993-1026. PubMed ID: 29873666
[TBL] [Abstract][Full Text] [Related]
35. A chemical dosimeter for the determination of the photodynamic activity of photosensitizers.
Fischer F; Graschew G; Sinn HJ; Maier-Borst W; Lorenz WJ; Schlag PM
Clin Chim Acta; 1998 Jun; 274(1):89-104. PubMed ID: 9681600
[TBL] [Abstract][Full Text] [Related]
36. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.
Jin CS; Cui L; Wang F; Chen J; Zheng G
Adv Healthc Mater; 2014 Aug; 3(8):1240-9. PubMed ID: 24464930
[TBL] [Abstract][Full Text] [Related]
37. Ultra-high loading of sinoporphyrin sodium in ferritin for single-wave motivated photothermal and photodynamic co-therapy.
Huang C; Chu C; Wang X; Lin H; Wang J; Zeng Y; Zhu W; Wang YJ; Liu G
Biomater Sci; 2017 Jul; 5(8):1512-1516. PubMed ID: 28617486
[TBL] [Abstract][Full Text] [Related]
38. Spectroscopic properties of porphyrin-like photosensitizers: insights from theory.
Petit L; Quartarolo A; Adamo C; Russo N
J Phys Chem B; 2006 Feb; 110(5):2398-404. PubMed ID: 16471831
[TBL] [Abstract][Full Text] [Related]
39. [Structural identification and quality study on isomers of a novel anticancer photosensitiser photocyanine].
Yang BB; Yao HS; Liu H; Jiang Z; Wang J; He WY; Wang Y; Chen NS; Huang JL
Yao Xue Xue Bao; 2010 Dec; 45(12):1545-9. PubMed ID: 21351495
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, spectroscopic properties and photodynamic activity of porphyrin-fullerene C60 dyads with application in the photodynamic inactivation of Staphylococcus aureus.
Ballatore MB; Spesia MB; Milanesio ME; Durantini EN
Eur J Med Chem; 2014 Aug; 83():685-94. PubMed ID: 25010938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
